ghk-cu plasma levels age 20 60 ng/ml decline The first order degradation profiles of in various medium stored GHK-Cu Peptides Before and After: – GHK-Cu Peptides Before and After:

In the animal model, BPC-157 inhibited the muscularization of pulmonary arteries, the pathological process that drives pulmonary hypertension

Product Name: BPC-157 Strength: 5mg Chemical Name: Body Protection Compound-157 CAS Number: 137525-51-0 Molecular Formula: CHNO Molecular Weight: 1419.56 g/mol Amino Acid Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Appearance: White to Off-White Lyophilized Powder Classification: Synthetic Pentadecapeptide Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) Research areas commonly associated with this compound include: Tissue Repair Healing & Inflammation Store lyophilized material refrigerated at 28C for routine storage

But systemic and deep dermal effects require systemic delivery

Presented for research literature review only Prkacin I et al